Martha J. Carter

Martha J. Carter (senior executive) discloses dealings in Albireo Pharma, Inc. to SEC (Form 4). Between 18 January 2022 and 2 March 2023, the trades on record add up to 10 filings.

On the market, this insider has only sold: 6 sales, €60k in total. Outside the open market, there are 3 share grants. So far in 2023, the count stands at no purchases and 2 sales.

The latest filing, published on 2 March 2023, reports a transaction in Albireo Pharma, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.